BURLINGTON, Mass., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central ...
The financial services company’s last quarter was a “validation” of its efforts to strengthen its balance sheet, CFO Perry ...
As of October 31, 2025, IP Strategy has staked 42.5 million unlocked $IP tokens, generating a cumulative 422,664 $IP tokens in validator rewards worth approximately $3.49 million in revenue based on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback